scholarly journals Influence of Clinical Anamnestic and Psychological Factors on Adherence to Treatment of Patients with Chronic Obstructive Pulmonary Disease

2021 ◽  
Vol 6 (6) ◽  
pp. 158-163
Author(s):  
H. I. Shumko ◽  
◽  
T. V. Reva ◽  
V. O. Shuper ◽  
M. I. Shumko ◽  
...  
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Pulmonary Disease ◽  
Psychological Factors ◽  
Chronic Obstructive ◽  
Adherence To Treatment ◽  
Obstructive Pulmonary Disease ◽  
Low Level ◽  
Personal Anxiety ◽  
High Level ◽  
The Impact

The purpose of the study was to determine the influence of various factors on the level of adherence to treatment in patients with chronic obstructive pulmonary disease. Materials and methods. We examined 75 people with chronic obstructive pulmonary disease aged 45 to 65 years. In the study we used clinical examination of patients, laboratory, instrumental research methods, analysis of medical records, statistical-analytical, as well as clinical-psychopathological and psychodiagnostic methods (Morisky Medication Adherence Scale, determination of the level of subjective control, anxiety with Spielberger-Khanin method, the level of depression in the Beck questionnaire). Results and discussion. According to the results of the testing, three groups of patients were identified: 24% of patients with high, 32% of medium and 44% of low adherence to the treatment. Comparing our results with the literature, we can confirm data on a relatively low level of adherence to treatment among patients with chronic diseases, in particular chronic obstructive pulmonary disease. According to anamnestic data, patients with a high level of adherence to treatment were mostly married (61.11%) and had higher education (50%). Clinically, they belonged to group C (50%) with severe III airway obstruction (50%). These patients expressed high satisfaction with the inhaler (61.11%) and regularly communicated with the doctor (72.22%) (p <0.05). Regular communication of the patient with the doctor and satisfaction with their inhaler has an extremely significant impact on the level of adherence to treatment. According to a psychological study, these patients had an external type of subjective control (66.67%), a high level of personal anxiety (50%) and a pronounced level of depression (38.89%) (p <0.05). Numerous scientific studies on the impact of patients' commitment to the treatment of psychological factors, especially the level of personal anxiety and depression, contain a wide variety of data, which may indicate the extremely complex nature of each individual. Patients with a low level of adherence to treatment had difficulty using an inhaler (60.61%) and insufficient communication with a physician (69.70%) (p <0.05). In addition, according to psychological research, they had an internal type of subjective control (57.58%), low levels of personal anxiety (42.42%), severe (45.46%) and moderate levels of depression (42.42%) (р <0.05). Conclusion. Thus, the level of adherence to treatment in the examined patients with chronic obstructive pulmonary disease is low. This is influenced by a large number of socio-demographic, clinical-anamnestic and psychological factors

scholarly journals ‘I’m fine!’: Assertions of lack of support need among patients with chronic obstructive pulmonary disease: A mixed-methods study

2021 ◽  
pp. 174239532110003
Author(s):  
A Carole Gardener ◽  
Caroline Moore ◽  
Morag Farquhar ◽  
Gail Ewing ◽  
Efthalia Massou ◽  
...  
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Pulmonary Disease ◽  
Mixed Method ◽  
Self Report ◽  
Design Stage ◽  
Chronic Obstructive ◽  
Support Needs ◽  
Obstructive Pulmonary Disease ◽  
Stage 1 ◽  
The Impact

Objectives To understand how people with Chronic Obstructive Pulmonary Disease (COPD) disavow their support needs and the impact on care. Methods Two stage mixed-method design. Stage 1 involved sub-analyses of data from a mixed-method population-based longitudinal study exploring the needs of patients with advanced COPD. Using adapted criteria from mental health research, we identified 21 patients who disavowed their needs from the 235 patient cohort. Qualitative interview transcripts and self-report measures were analysed to compare these patients with the remaining cohort. In stage 2 focus groups (n = 2) with primary healthcare practitioners (n = 9) explored the implications of Stage 1 findings. Results Patients who disavowed their support needs described non-compliance with symptom management and avoidance of future care planning (qualitative data). Analysis of self-report measures of mental and physical health found this group reported fewer needs than the remaining sample yet wanted more GP contact. The link between risk factors and healthcare professional involvement present in the rest of the sample was missing for these patients. Focus group data suggested practitioners found these patients challenging. Discussion This study identified patients with COPD who disavow their support needs, but who also desire more GP contact. GPs report finding these patients challenging to engage.

scholarly journals The impact of age on outcomes in chronic obstructive pulmonary disease differs by relationship status

2013 ◽  
Vol 37 (4) ◽  
pp. 654-663 ◽  
Author(s):  
Kristen E. Holm ◽  
Melissa R. Plaufcan ◽  
Dee W. Ford ◽  
Robert A. Sandhaus ◽  
Matthew Strand ◽  
...  
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Pulmonary Disease ◽  
Relationship Status ◽  
Chronic Obstructive ◽  
Obstructive Pulmonary Disease ◽  
The Impact

The impact of virtual admission on self-efficacy in patients with chronic obstructive pulmonary disease - a randomised clinical trial

2014 ◽  
Vol 23 (21-22) ◽  
pp. 3124-3137 ◽  
Author(s):  
Christina Emme ◽  
Erik L Mortensen ◽  
Susan Rydahl-Hansen ◽  
Birte Østergaard ◽  
Anna Svarre Jakobsen ◽  
...  
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Clinical Trial ◽  
Pulmonary Disease ◽  
Self Efficacy ◽  
Randomised Clinical Trial ◽  
Chronic Obstructive ◽  
Obstructive Pulmonary Disease ◽  
The Impact

Bronchodilator and anti-inflammatory therapy of chronic obstructive pulmonary disease from the position of interchangeability

2021 ◽  
Vol 31 (4) ◽  
pp. 518-529
Author(s):  
E. A. Orlova ◽  
I. P. Dorfman ◽  
M. A. Orlov ◽  
A. K. Andreeva ◽  
M. A. Abdullaev
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Pulmonary Disease ◽  
Generic Drugs ◽  
The State ◽  
Chronic Obstructive ◽  
Anticholinergic Drugs ◽  
Adherence To Treatment ◽  
Obstructive Pulmonary Disease ◽  
State Register ◽  
Anti Inflammatory

The choice of drugs used to treat patients with chronic obstructive pulmonary disease (COPD) (inhaled β-agonists, M-anticholinergic drugs, inhaled corticosteroids (ICS)) in view of their interchangeability is reviewed in this article. This aspect is especially important for clinicians when choosing an effective and safe treatment for COPD and for increasing patient adherence to treatment.The aim of this study was to assess the ratio of the number of reference (original), interchangeable, and generic drugs used in COPD.Methods. In accordance with the Russian clinical guidelines 2018 and GOLD 2019, modern drugs for the treatment of COPD with bronchodilator and anti-inflammatory activity were selected. All trade names of the corresponding drugs for each international non-proprietary name (INN) In the State Register of Medicines website were considered. The information on the availability of reference (original) drugs and the corresponding interchangeable products, as well as their presence in the List of vital and essential drugs was analyzed.Results. A large number of generic prodcuts are registered in the State Register of Medicines, and only a few of them are interchangeable with the corresponding reference (original) drug.Conclusion. The analysis will help widen the doctors’ choice of interchangeable drugs in treatment of COPD with an equivalent effect and safety of reference drugs, as well as to increase the patients’ adherence to treatment.

The state of the cardiovascular system in occupational bronchitis and chronic obstructive pulmonary disease, not associated with the impact of harmful industrial factors

2021 ◽  
pp. 55-68
Author(s):  
Vyacheslav S. Lotkov ◽  
Anton Vladimirovich Glazistov ◽  
Antonina G. Baykova ◽  
Marina Yuryevna Vostroknutova ◽  
Natalia E. Lavrentieva
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Cardiovascular System ◽  
Pulmonary Disease ◽  
Lung Diseases ◽  
Chronic Obstructive ◽  
External Respiration ◽  
Obstructive Pulmonary Disease ◽  
Occupational Lung Diseases ◽  
The Right ◽  
The Impact

The formation and progression of chronic dust bronchitis and chronic bronchitis of toxic-chemical etiology, chronic obstructive pulmonary disease is accompanied by an increase in the degree of ventilation disorders, echocardiographic signs of hypertrophy and dilatation of the right ventricle are formed, typical for chronic pulmonary heart disease. The progression of disturbances in the function of external respiration in dusty lung diseases leads to a decrease in myocardial contractility. The detection of hemodynamic disturbances at the early stages of the development of occupational lung diseases indicates the need for individual monitoring of the functional state of the cardiovascular system in the process of contact with industrial aerosols, especially in groups of workers with long-term exposure.

Sign in / Sign up

Export Citation Format

Share Document